The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Controlling ligand substitution reactions of organometallic complexes: Tuning cancer cell cytotoxicity
Open accessAbstract
Organometallic compounds offer broad scope for the design of therapeutic agents, but this avenue has yet to be widely explored. A key concept in the design of anticancer complexes is optimization of chemical reactivity to allow facile attack on the target site (e.g., DNA) yet avoid attack on other sites associated with unwanted side effects. Here, we consider how this result can be achieved for monofunctional “piano-stool” ruthenium(II) arene complexes of the type [(η 6-arene)Ru(ethylenediamine)(X)]n+. A potentially important activation mechanism for reactions with biomolecules is hydrolysis. Density functional calculations suggested that aquation (substitution of X by H 2 O) occurs by means of a concerted ligand interchange mechanism. We studied the kinetics and equilibria for hydrolysis of 21 complexes, containing, as X, halides and pseudohalides, pyridine (py) derivatives, and a thiolate, together with benzene (bz) or a substituted bz as arene, using UV-visible spectroscopy, HPLC, and electrospray MS. The x-ray structures of six complexes are reported. In general, complexes that hydrolyze either rapidly {e.g., X = halide [arene = hexamethylbenzene (hmb)]} or moderately slowly [e.g., X = azide, dichloropyridine (arene = hmb)] are active toward A2780 human ovarian cancer cells, whereas complexes that do not aquate (e.g., X = py) are inactive. An intriguing exception is the X = thiophenolate complex, which undergoes little hydrolysis and appears to be activated by a different mechanism. The ability to tune the chemical reactivity of this class of organometallic ruthenium arene compounds should be useful in optimizing their design as anticancer agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
te Velde, G., Bickelhaupt, F. M., Baerends, E. J., Fonseca Guerra, C., van Gisbergen, S. J. A., Snijders, J. G., & Ziegler, T. (2001) · Journal of Computational Chemistry · doi:10.1002/jcc.1056 · Cited by 10,152
Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug
(1999) · Wiley eBooks · doi:10.1002/9783906390420 · Cited by 1,296
Inhibition of Cancer Cell Growth by Ruthenium(II) Arene Complexes
Morris, R. E., Aird, R. E., del Socorro Murdoch, P., Chen, H., Cummings, J., Hughes, N. D., Parsons, S., Parkin, A., Boyd, G., Jodrell, D. I., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010051m · Cited by 787
Self-citationRuthenium metallopharmaceuticals
Clarke, M. J. (2003) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00312-0 · Cited by 687
New clues for platinum antitumor chemistry: Kinetically controlled metal binding to DNA
Reedijk, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737293100 · Cited by 617
Aird, R. E., Cummings, J., Ritchie, A. A., Muir, M., Morris, R. E., Chen, H., Sadler, P. J., & Jodrell, D. I. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600290 · Cited by 582
Self-citationNon-platinum group metal antitumor agents. History, current status, and perspectives
Koepf-Maier, P., & Koepf, H. (1987) · Chemical Reviews · doi:10.1021/cr00081a012 · Cited by 509
Guo, Z., & Sadler, P. J. (1999) · Advances in Inorganic Chemistry · doi:10.1016/s0898-8838(08)60271-8 · Cited by 354
Self-citationMechanisms of Inorganic Reactions; A Study of Metal Complexes in Solution
Basola, F., Pearson, R. G., & Williams, D. D. (1959) · Journal of The Electrochemical Society · doi:10.1149/1.2427160 · Cited by 348
Fish, R. H., & Jaouen, G. (2003) · Organometallics · doi:10.1021/om0300777 · Cited by 328
Wang, F., Chen, H., Parsons, S., Oswald, I. D. H., Davidson, J. E., & Sadler, P. J. (2003) · Chemistry – A European Journal · doi:10.1002/chem.200304724 · Cited by 254
Self-citationControlling platinum, ruthenium, and osmium reactivity for anticancer drug design
Bruijnincx, P. C. A., & Sadler, P. J. (2009) · Advances in Inorganic Chemistry · doi:10.1016/s0898-8838(09)00201-3 · Cited by 218
Self-citationDadci, L., Elias, H., Frey, U., Hoernig, A., Koelle, U., Merbach, A. E., Paulus, H., & Schneider, J. S. (1995) · Inorganic Chemistry · doi:10.1021/ic00105a048 · Cited by 208
Inorganic Chemistry and Drug Design
Sadler, P. J. (1991) · Advances in Inorganic Chemistry · doi:10.1016/s0898-8838(08)60035-5 · Cited by 199
Self-citationWang, F., Xu, J., Habtemariam, A., Bella, J., & Sadler, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053387k · Cited by 169
Self-citationRapaport, I., Helm, L., Merbach, A. E., Bernhard, P., & Lüdi, A. (1988) · Inorganic Chemistry · doi:10.1021/ic00278a025 · Cited by 145
Induced-fit recognition of DNA by organometallic complexes with dynamic stereogenic centers
Chen, H., Parkinson, J. A., Nováková, O., Bella, J., Wang, F., Dawson, A., Gould, R. O., Parsons, S., Brabec, V., & Sadler, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434016100 · Cited by 125
Self-citationReactions of a Ruthenium(II) Arene Antitumor Complex with Cysteine and Methionine
Wang, F., Chen, H., Parkinson, J. A., Murdoch, P. D. S., & Sadler, P. J. (2002) · Inorganic Chemistry · doi:10.1021/ic025538f · Cited by 121
Self-citationStebler-Roethlisberger, M., Hummel, W., Pittet, P. A., Buergi, H. B., Lüdi, A., & Merbach, A. E. (1988) · Inorganic Chemistry · doi:10.1021/ic00281a009 · Cited by 118
Jennerwein, M., & Andrews, P. A. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06515-8 · Cited by 79
Organometallic chemistry at the threshold of a new millennium. Retrospect and prospect
Halpern, J. (2001) · Pure and Applied Chemistry · doi:10.1351/pac200173020209 · Cited by 44
Cited by
Zeng, L., Gupta, P., Chen, Y., Wang, E., Ji, L., Chao, H., & Chen, Z.-S. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00195a · Cited by 1,017
Metal Complexes as DNA Intercalators
Liu, H.-K., & Sadler, P. J. (2011) · Accounts of Chemical Research · doi:10.1021/ar100140e · Cited by 749
Self-citationMetallodrugs are unique: opportunities and challenges of discovery and development
Anthony, E. J., Bolitho, E. M., Bridgewater, H. E., Carter, O. W. L., Donnelly, J. M., Imberti, C., Lant, E. C., Lermyte, F., Needham, R. J., Palau, M., et al. (2020) · Chemical Science · doi:10.1039/d0sc04082g · Cited by 692
Self-citationToward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Using coordination chemistry to design new medicines
Ronconi, L., & Sadler, P. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.11.017 · Cited by 608
Self-citation
Metadata
- Authors
- Wang, F., Habtemariam, A., van der Geer, E. P. L., Fernández, R., Melchart, M., Deeth, R. J., Aird, R., Guichard, S., Fabbiani, F. P. A., Lozano-Casal, P., Oswald, I. D. H., Jodrell, D. I., Parsons, S., & Sadler, P. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-12-13
- Volume
- 102
- Issue
- 51
- Pages
- 18269-18274
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2023653247
- Cited by
- 308
- References
- 21
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.